MLTX - Company ID 0001821586
As of 2026-11-06, MoonLake Immunotherapeutics (MLTX) has a market capitalization of $813.45 M, making it the #2584 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $813.45 M |
| 2026-11-05 | $795.05 M |
| 2026-11-04 | $839.22 M |
| 2026-11-03 | $858.36 M |
| 2026-11-02 | $844.37 M |
| 2026-11-01 | $867.19 M |
| 2026-10-31 | $867.19 M |
| 2026-10-30 | $892.95 M |
| 2026-10-29 | $925.35 M |
| 2026-10-28 | $907.31 M |
| 2026-10-27 | $873.81 M |
| 2026-10-26 | $869.40 M |
As of 2026-11-06, MoonLake Immunotherapeutics (MLTX) has a market capitalization of $813.45 M, making it the #2584 most valuable US-listed company.
MoonLake Immunotherapeutics is the #2584 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $872.34 M |
| 2026-10-24 | $872.34 M |
| 2026-10-23 | $872.34 M |
| 2026-10-22 | $931.23 M |
| 2026-10-21 | $784.00 M |
| 2026-10-20 | $759.71 M |
| 2026-10-19 | $717.75 M |
| 2026-10-18 | $703.03 M |
| 2026-10-17 | $703.03 M |
| 2026-10-16 | $703.03 M |
| 2026-10-15 | $763.39 M |
| 2026-10-14 | $746.46 M |
| 2026-10-13 | $766.34 M |
| 2026-10-12 | $786.21 M |
| 2026-10-11 | $796.52 M |
| 2026-10-10 | $796.52 M |
| 2026-10-09 | $796.52 M |
| 2026-10-08 | $778.85 M |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.